Voxelotor improves red blood cell functionality in children with sickle cell anaemia: An ancillary study of the HOPE‐KIDS 1 trial

Documenti analoghi

• Changes in indicators of cerebral metabolic stress following treatment with voxelotor in children and adolescents with sickle cell anemia
  di: Andrew M. Heitzer, et al.
  Pubblicazione: (2024)
• Haemoglobin Ottawa, sickle cell trait and vaso‐occlusive crises
  di: Cécile Bobillier, et al.
  Pubblicazione: (2024)
• Coinheritance of non‐deletional hemoglobin H disease with sickle cell trait
  di: Veroniki Komninaka, et al.
  Pubblicazione: (2024)
• Prophylactic versus on‐demand transfusion in pregnant women with sickle cell disease: A systematic review and meta‐analysis of randomised controlled trials
  di: Denise Menezes Brunetta, et al.
  Pubblicazione: (2025)
• Positive impacts of universal newborn screening on the outcome of children with sickle cell disease in the province of Quebec: A retrospective cohort study
  di: Costa Kazadi, et al.
  Pubblicazione: (2024)